November 27, 2021

News Science

The Science of News

FDA advisory panel recommends Johnson and Johnson booster shot

2 min read

The FDA advisory panel unanimously voted to recommend the Johnson and Johnson booster shot on Friday. It comes a day after the same panel made the recommendation for a third Moderna shot. President Biden says full FDA and CDC approval for both boosters could come as early as next week. CBS News reporter Max Bayer and John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, join CBSN’s Tanya Rivero to discuss the FDA panel’s vote.

CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the Paramount+ subscription service.

Subscribe to the CBS News YouTube channel: http://youtube.com/cbsnews​
Watch CBSN live: http://cbsn.ws/1PlLpZ7c​
Download the CBS News app: http://cbsn.ws/1Xb1WC8​
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/​
Like CBS News on Facebook: http://facebook.com/cbsnews​
Follow CBS News on Twitter: http://twitter.com/cbsnews​
Subscribe to our newsletters: http://cbsn.ws/1RqHw7T​
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video licensing inquiries, contact: licensing@veritone.com

Source: CBS News

More News

News Science © 2005 Area.Control.Network™ All rights reserved.
All Rights Reserved © 2020 - 2021 Area Control Network (ACN)
The ACN News websites News.Science use Area Control Network TOS and Privacy Policies that you must agree to to use this site.
Privacy Policies & TOS